August 7, 2014 was the official opening of the company’s first advanced recombinant biologic production facility in Singapore. It is located at Woodlands Industrial Park, occupying 150,000 square feet. ADVATE, a type of protein used in the treatment of haemophilia, is produced in this facility. It employs more than 400 people. Baxter also plans on opening a second processing suite, which is expected to open in 2017. Baxter’s expansion reinforces Singapore’s position as a leading biologics hub.